OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Equity Capital Raises

Equity Transaction Chart

Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Equity Commentary

Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.

Equity Raises:

  • On September 24, 2024, Glow LifeTech Corp. (GLOW: CSE)(GLWLF: OTCQB), a Canadian biotech company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, closed a Private Placement of Units with gross proceeds of $.89M.
  • Each Unit included a whole warrant with an 18-month maturity and a 67% exercise premium. The short life and large premium reduced the value of the warrant package to less than $.001 per share.
  • The transaction values the company at a market cap of approximately $2.64M and an E.V./ Annualized Revenue of roughly 3.8x.

Public vs. Private Raises: 

  • Both capital raisers this week are public and trade both in Canada on the CSE and in the U.S. (one on OTCQB and one on OTCQX).

Equity vs. Debt Cap Raises:

  • Equity accounted for 51% of the week’s capital raise activity.